Charles Rhyee
Stock Analyst at TD Cowen
(0.83)
# 3,833
Out of 4,905 analysts
52
Total ratings
32.35%
Success rate
-13.37%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Downgrades: Hold | $254 → $157 | $143.54 | +9.38% | 4 | Apr 14, 2025 | |
| MEDP Medpace Holdings | Downgrades: Hold | $370 → $328 | $311.87 | +5.17% | 4 | Apr 14, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $159.56 | -9.75% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $154.48 | +46.94% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $4.69 | +433.05% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $8.05 | -0.62% | 6 | Oct 31, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $282.29 | -31.98% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.68 | +241.88% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $2.48 | +101.61% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $8.07 | +519.58% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $160.63 | +56.26% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $8.02 | +598.25% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.69 | +1,940.82% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $9.53 | +424.66% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $709.80 | -49.14% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $0.56 | +578,471.43% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $20.95 | +67.06% | 1 | Feb 13, 2018 |
ICON Public Limited Company
Apr 14, 2025
Downgrades: Hold
Price Target: $254 → $157
Current: $143.54
Upside: +9.38%
Medpace Holdings
Apr 14, 2025
Downgrades: Hold
Price Target: $370 → $328
Current: $311.87
Upside: +5.17%
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $159.56
Upside: -9.75%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $154.48
Upside: +46.94%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $4.69
Upside: +433.05%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $8.05
Upside: -0.62%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $282.29
Upside: -31.98%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.68
Upside: +241.88%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $2.48
Upside: +101.61%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $8.07
Upside: +519.58%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $160.63
Upside: +56.26%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $8.02
Upside: +598.25%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.69
Upside: +1,940.82%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $9.53
Upside: +424.66%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $709.80
Upside: -49.14%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $0.56
Upside: +578,471.43%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $20.95
Upside: +67.06%